Stories
Slash Boxes
Comments

SoylentNews is people

SoylentNews is powered by your submissions, so send in your scoop. Only 15 submissions in the queue.
posted by CoolHand on Tuesday April 21 2015, @06:46PM   Printer-friendly
from the trial-wonders-that-we-never-see-in-real-life dept.

SBS Australia reports that a dual therapy of antiviral drug and anti-cancer drugs was 100 percent successful in eliminating the hepatitis B virus (HBV) infections in pre-clinical animal trials. The combination treatment targets the cell signalling pathways that the hepatitis B virus uses to keep host liver cells alive.

Researcher Marc Pellegrini said "We are hopeful these promising results will be as successful in human clinical trials, which are currently underway in Melbourne, Perth and Adelaide,"

http://www.sbs.com.au/news/article/2015/04/21/new-treatment-promising-hep-b

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 0) by Anonymous Coward on Tuesday April 21 2015, @10:08PM

    by Anonymous Coward on Tuesday April 21 2015, @10:08PM (#173710)

    Save your "Boo" for the politicians that decide to do bad things with technologies developed by scientists and engineers.